Measurable residual disease of canonical versus non-canonical DNMT3A, TET2, or ASXL1 mutations in AML at stem cell transplantation.

ABSTRACT:

SUBMITTER: Jentzsch M 

PROVIDER: S-EPMC8486652 | biostudies-literature | 2021 Oct

REPOSITORIES: biostudies-literature